Transcription of Creating Value Through China Partnering - torreya.com
{{id}} {{{paragraph}}}
Example: confidence
Creating Value Through China Partnering - torreya.com
Creating Value Through China Partnering October 2018. Securities offered in the United States are offered Through Torreya Capital LLC, Member FINRA/SIPC. In Europe such services are offered Through Torreya Partners (Europe) LLP, which is authorized and regulated by the UK Financial Conduct Authority. Table of Contents Preface & Executive Summary 3. Background on the China Pharmaceutical Market 7. The Evolving Drug Approval Process in China 13. Health in China 26. Intellectual Property Protection in China 34. China In- licensing and Deal Statistics 40. Most Important Licensees in China 50. Getting a China licensing Deal Done 59. Structuring a China Deal 73.
1. China licensing activity has skyrocketed. • Thus far in 2018, we have seen more than five deals a month announced, on average. • In contrast, five years ago (2014) there was roughly one deal a month announced. 2. The value of licensing activity in China has also risen. • The average upfront payment on a licensing deal in 2018 was $11.7 million (including pre-
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: